Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGS - Nasdaq Real Time Price USD

The Cooper Companies, Inc. (COO)

Compare
83.77
-1.21
(-1.42%)
At close: March 28 at 4:00:02 PM EDT
83.77
0.00
(0.00%)
After hours: March 28 at 4:20:00 PM EDT
Loading Chart for COO
  • Previous Close 84.98
  • Open 84.54
  • Bid 83.59 x 1000
  • Ask 90.33 x 100
  • Day's Range 83.40 - 85.10
  • 52 Week Range 77.05 - 112.38
  • Volume 1,736,366
  • Avg. Volume 1,851,979
  • Market Cap (intraday) 16.75B
  • Beta (5Y Monthly) 1.02
  • PE Ratio (TTM) 40.47
  • EPS (TTM) 2.07
  • Earnings Date May 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jul 26, 2023
  • 1y Target Est 107.41

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia; and spherical lense, including lenses that correct near and farsightedness in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including paragard contraceptive intrauterine devices; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

www.coopercos.com

16,000

Full Time Employees

October 31

Fiscal Year Ends

Recent News: COO

View More

Performance Overview: COO

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

COO
8.88%
S&P 500 (^GSPC)
5.11%

1-Year Return

COO
17.44%
S&P 500 (^GSPC)
6.22%

3-Year Return

COO
18.80%
S&P 500 (^GSPC)
21.97%

5-Year Return

COO
22.71%
S&P 500 (^GSPC)
119.59%

Compare To: COO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: COO

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    16.75B

  • Enterprise Value

    19.19B

  • Trailing P/E

    40.47

  • Forward P/E

    20.96

  • PEG Ratio (5yr expected)

    1.43

  • Price/Sales (ttm)

    4.28

  • Price/Book (mrq)

    2.06

  • Enterprise Value/Revenue

    4.88

  • Enterprise Value/EBITDA

    17.52

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.57%

  • Return on Assets (ttm)

    3.80%

  • Return on Equity (ttm)

    5.25%

  • Revenue (ttm)

    3.93B

  • Net Income Avi to Common (ttm)

    415.4M

  • Diluted EPS (ttm)

    2.07

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    100.9M

  • Total Debt/Equity (mrq)

    31.25%

  • Levered Free Cash Flow (ttm)

    243M

Research Analysis: COO

View More

Company Insights: COO

Research Reports: COO

View More

People Also Watch